MCH ADVISORY RESEARCHMain site ↗
Financials

Life & Health Insurance

9 companies under coverage.

Coverage

Life & Health Insurance


Equity Research

Brighthouse Financial, Inc. (BHF)

BUY. 12-month probability-weighted target $129 (+147% vs spot). P/E Multiple explains 60% of Monte Carlo outcome variance.

BHFEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +158.4%
Equity Research

Primerica Inc (PRI)

HOLD. 12-month probability-weighted target $309 (+7% vs spot). P/E Multiple explains 65% of Monte Carlo outcome variance.

PRIEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +12.1%
Equity Research

Globe Life Inc (GL)

HOLD. 12-month probability-weighted target $176 (+3% vs spot). P/E Multiple explains 67% of Monte Carlo outcome variance.

GLEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +11.1%
Equity Research

Aflac Incorporated (AFL)

HOLD. 12-month probability-weighted target $122 (+6% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

AFLEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +1.7%
Equity Research

Prudential Financial, Inc. (PRU)

SELL. 12-month probability-weighted target $105 (-12% vs spot). Gross Margin explains 65% of Monte Carlo outcome variance.

PRUEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -12.6%
Equity Research

Principal Financial Group Inc (PFG)

HOLD. 12-month probability-weighted target $106 (-8% vs spot). P/E Multiple explains 55% of Monte Carlo outcome variance.

PFGEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -14.2%
Equity Research

MetLife Inc (MET)

SELL. 12-month probability-weighted target $84 (-12% vs spot). Gross Margin explains 66% of Monte Carlo outcome variance.

METEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -20.0%
Equity Research

CNO Financial Group Inc (CNO)

HOLD. 12-month probability-weighted target $55 (-1% vs spot). Gross Margin explains 55% of Monte Carlo outcome variance.

CNOEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -21.3%
Equity Research

Unum Group (UNM)

HOLD. 12-month probability-weighted target $86 (-8% vs spot). Gross Margin explains 48% of Monte Carlo outcome variance.

UNMEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -28.7%
MCH ADVISORY SERVICES · All research · Research, not personalised investment advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.20.0 · US-listed